Rainier Therapeutics, Inc. — Form D

Rainier Therapeutics, Inc. of SAN LEANDRO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-12. The offering totals $20.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Jack L NielsenDirectorHarrisburg, PA
Scott D MyersDirectorWatertown, MA
Scott D MyersExecutive OfficerWatertown, MA
Graeme M CurrieExecutive OfficerSan Leandro, CA
Julie M EastlandExecutive OfficerSan Leandro, CA
David L KabakoffDirectorSan Leandro, CA
Joel L Jean-MairetDirectorSan Leandro, CA
Christian L RichardDirectorSan Leandro, CA
Fouad L AzzamDirectorSan Leandro, CA
Marten L SteenDirectorSan Leandro, CA
Steve M AbellaExecutive OfficerSan Leandro, CA
Steve L AbellaExecutive OfficerSan Leandro, CA
Graeme L CurrieExecutive OfficerSan Leandro, CA
Stephen W LauDirectorSan Leandro, CA
Stephen W LauExecutive OfficerSan Leandro, CA
Cory L FreedlandDirectorSan Ramon, CA
Eric D EmeryExecutive OfficerSan Ramon, CA
Brent D FassettExecutive OfficerSan Ramon, CA
Jocelyn D HolashExecutive OfficerSan Ramon, CA
Joseph L TurnerDirectorMountain View, CA
Stephen LauDirectorToronto, A6
Stephen LauExecutive OfficerToronto, A6
Thomas L BooneDirectorSan Ramon, CA
Kenneth L SchwartzExecutive OfficerSan Ramon, CA
Eric L YuenExecutive OfficerSan Ramon, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2019-07-26D$19.2M$10.0M
2018-05-14D/A$50.0M$50.0M
2017-03-21D$30.0M$20.0M
2014-06-04D$10.0M$10.0M
2014-04-17D$6.0M$6.0M

More